Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

LeGoo¿ Endovascular Occlusion Gel-2.5 mL LeGoo w/ no Cannula Product Recalled by Genzyme Corporation, A Sanofi Company Due to Product contains particulates (fibers)

Date: June 21, 2013
Company: Genzyme Corporation, A Sanofi Company
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Genzyme Corporation, A Sanofi Company directly.

Affected Products

LeGoo¿ Endovascular Occlusion Gel-2.5 mL LeGoo w/ no Cannula Product Number: PV-250 LeGoo is a water-soluble, biocompatible polymer with reverse thermo-sensitive properties allowing it to be injected as a soft viscoelastic gel that forms an elastic plug within the vessel. LeGoo is indicated for temporary endovascular occlusion of blood vessels up to 4 mm in diameter below the neck.

Quantity: 250 units

Why Was This Recalled?

Product contains particulates (fibers)

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About Genzyme Corporation, A Sanofi Company

Genzyme Corporation, A Sanofi Company has 18 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report